-
1
-
-
15544391275
-
Parkinson's disease: in vivo assessment of disease progression using positron emission tomography
-
Au W.L., Adams J.R., Troiano A.R., and Stoessl A.J. Parkinson's disease: in vivo assessment of disease progression using positron emission tomography. Mol. Brain Res. 134 1 (2005) 24-33
-
(2005)
Mol. Brain Res.
, vol.134
, Issue.1
, pp. 24-33
-
-
Au, W.L.1
Adams, J.R.2
Troiano, A.R.3
Stoessl, A.J.4
-
2
-
-
33846923326
-
Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain
-
Casteels C., Vermaelen P., Nuyts J., Van Der Linden A., Baekelandt V., Mortelmans L., Bormans G., and Van Laere K. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain. J. Nucl. Med. 47 11 (2006) 1858-1866
-
(2006)
J. Nucl. Med.
, vol.47
, Issue.11
, pp. 1858-1866
-
-
Casteels, C.1
Vermaelen, P.2
Nuyts, J.3
Van Der Linden, A.4
Baekelandt, V.5
Mortelmans, L.6
Bormans, G.7
Van Laere, K.8
-
3
-
-
0030276777
-
18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography
-
18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl. Med. Biol. 23 8 (1996) 999-1004
-
(1996)
Nucl. Med. Biol.
, vol.23
, Issue.8
, pp. 999-1004
-
-
Chaly, T.1
Dhawan, V.2
Kazumata, K.3
Antonini, A.4
Margouleff, C.5
Dahl, J.R.6
Belakhlef, A.7
Margouleff, D.8
Yee, A.9
Wang, S.10
Tamagnan, G.11
Neumeyer, J.L.12
Eidelberg, D.13
-
6
-
-
37449005975
-
Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [(18)F]FECT
-
Chitneni S.K., Garreau L., Cleynhens B., Evens N., Bex M., Vermaelen P., Chalon S., Busson R., Guilloteau D., Van Laere K., Verbruggen A., and Bormans G. Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [(18)F]FECT. Nucl. Med. Biol. 35 1 (2008) 75-82
-
(2008)
Nucl. Med. Biol.
, vol.35
, Issue.1
, pp. 75-82
-
-
Chitneni, S.K.1
Garreau, L.2
Cleynhens, B.3
Evens, N.4
Bex, M.5
Vermaelen, P.6
Chalon, S.7
Busson, R.8
Guilloteau, D.9
Van Laere, K.10
Verbruggen, A.11
Bormans, G.12
-
8
-
-
0028337480
-
Synthesis and characterization of radioiodinated N-(3-iodopropen-1-Yl)-2-beta-carbomethoxy-3-beta-(4-chlorophenyl)tropane S-potential dopamine reuptake site imaging agents
-
Goodman M.M., Kung M.P., Kabalka G.W., Kung H.F., and Switzer R. Synthesis and characterization of radioiodinated N-(3-iodopropen-1-Yl)-2-beta-carbomethoxy-3-beta-(4-chlorophenyl)tropane S-potential dopamine reuptake site imaging agents. J. Med. Chem. 37 10 (1994) 1535-1542
-
(1994)
J. Med. Chem.
, vol.37
, Issue.10
, pp. 1535-1542
-
-
Goodman, M.M.1
Kung, M.P.2
Kabalka, G.W.3
Kung, H.F.4
Switzer, R.5
-
9
-
-
17344383647
-
Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters
-
Goodman M.M., Keil R., Shoup T.M., Eshima D., Eshima L., Kilts C., Votaw J., Camp V.M., Votaw D., Smith E., Kung M.-P., Malveaux E., Watts R., Huerkamp M., Wu D., Garcia E., and Hoffman J.M. Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters. J. Nucl. Med. 38 1 (1997) 119-126
-
(1997)
J. Nucl. Med.
, vol.38
, Issue.1
, pp. 119-126
-
-
Goodman, M.M.1
Keil, R.2
Shoup, T.M.3
Eshima, D.4
Eshima, L.5
Kilts, C.6
Votaw, J.7
Camp, V.M.8
Votaw, D.9
Smith, E.10
Kung, M.-P.11
Malveaux, E.12
Watts, R.13
Huerkamp, M.14
Wu, D.15
Garcia, E.16
Hoffman, J.M.17
-
10
-
-
0033625020
-
18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters
-
18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Nucl. Med. Biol. 27 1 (2000) 1-12
-
(2000)
Nucl. Med. Biol.
, vol.27
, Issue.1
, pp. 1-12
-
-
Goodman, M.M.1
Kilts, C.D.2
Keil, R.3
Shi, B.4
Martarello, L.5
Xing, D.6
Votaw, J.7
Ely, T.D.8
Lambert, P.9
Owens, M.J.10
Camp, V.M.11
Malveaux, E.12
Hoffman, J.M.13
-
11
-
-
0345770368
-
Role of dopamine transporter imaging in routine clinical practice
-
Marshall V., and Grosset D. Role of dopamine transporter imaging in routine clinical practice. Movement Disord. 18 12 (2003) 1415-1423
-
(2003)
Movement Disord.
, vol.18
, Issue.12
, pp. 1415-1423
-
-
Marshall, V.1
Grosset, D.2
-
12
-
-
0027468956
-
Substituted 3-phenyltropane analogs of cocaine-synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging
-
Meltzer P.C., Liang A.Y., Brownell A.L., Elmaleh D.R., and Madras B.K. Substituted 3-phenyltropane analogs of cocaine-synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging. J. Med. Chem. 36 7 (1993) 855-862
-
(1993)
J. Med. Chem.
, vol.36
, Issue.7
, pp. 855-862
-
-
Meltzer, P.C.1
Liang, A.Y.2
Brownell, A.L.3
Elmaleh, D.R.4
Madras, B.K.5
-
13
-
-
4344618164
-
18F]fluoroet hyl)nortropane) as a dopamine transporter ligand: a PET study in the conscious monkey brain
-
18F]fluoroet hyl)nortropane) as a dopamine transporter ligand: a PET study in the conscious monkey brain. Synapse 54 1 (2004) 37-45
-
(2004)
Synapse
, vol.54
, Issue.1
, pp. 37-45
-
-
Harada, N.1
-
14
-
-
0021260262
-
A new reagent for the selective, high-yield N-dealkylation of tertiary amines: improved syntheses of naltrexone and nalbuphine
-
Olofson R.A., Martz J.T., Senet J.-P., Piteau M., and Malfroot T. A new reagent for the selective, high-yield N-dealkylation of tertiary amines: improved syntheses of naltrexone and nalbuphine. J. Org. Chem. 49 11 (1984) 2081-2082
-
(1984)
J. Org. Chem.
, vol.49
, Issue.11
, pp. 2081-2082
-
-
Olofson, R.A.1
Martz, J.T.2
Senet, J.-P.3
Piteau, M.4
Malfroot, T.5
-
15
-
-
33748847295
-
Parkinson's disease and dopamine transporter neuroimaging: a critical review
-
Shih M.C., Hoexter M.Q., Andrade L.A., and Bressan R.A. Parkinson's disease and dopamine transporter neuroimaging: a critical review. Sao Paulo Med. J. 124 3 (2006) 168-175
-
(2006)
Sao Paulo Med. J.
, vol.124
, Issue.3
, pp. 168-175
-
-
Shih, M.C.1
Hoexter, M.Q.2
Andrade, L.A.3
Bressan, R.A.4
|